Last reviewed · How we verify
NCT03820245
Effect of Short-term Annatto Carotenoids Supplementation on Oxidative Stress Status in Healthy Individuals
NA trial testing Bixin in Oxidative Stress in 16 participants. Completed in 25 July 2018.
15 April 2018
Quick facts
| Lead sponsor | Universidade Federal de Santa Maria |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 16 |
| Start date | 24 August 2016 |
| Primary completion | 15 April 2018 |
| Estimated completion | 25 July 2018 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Bixin
- Norbixin
- Lycopene (LYCOPENE) — full drug profile →
- Placebo
Conditions studied
- Oxidative Stress — all drugs for Oxidative Stress →
- Atherosclerosis — all drugs for Atherosclerosis →
Sponsor
Universidade Federal de Santa Maria — full company profile →
Who can join
Adults 18 to 35, any sex, with Oxidative Stress or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Low-density lipoprotein (LDL) oxidation has a pivotal role in atherosclerosis development. There is a relationship between carotenoids serum concentration and cardiovascular (CV) benefits, mainly in oxidized LDL (oxLDL) reduction. Despite cardio protective effects of annatto carotenoids, bixin and norbixin, in vitro and in animal studies, its short or long-term supplementation effect on humans are not know. Objective: To analyse CV benefits of annatto carotenoids short-term supplementation in healthy individuals, comparing to lycopene effect. Methods: 16 healthy volunteers (8 men and 8 women) consumed 0.05 mg/kg b.w. of each treatment (bixin, norbixin, lycopene or placebo) through capsules, during 7 days. It was analysed the susceptibility of LDL to Cu2+-induced oxidation, biochemical parameters and oxidative stress biomarkers at the beginning and end of each treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Anti-oxidative stress treatment and current clinical trials.
Zhang CY, Yang M. · · 2024 · cited 3× · PMID 38495278 · DOI 10.4254/wjh.v16.i2.294
Verify or expand the search:
- PubMed search for NCT03820245
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oxidative Stress
Currently open trials in the same condition.
- NCT07375238 — Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress · NA · recruiting
- NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
- NCT07244809 — Probing the Role of Mitochondrial Oxidative Stress in Impaired Vascular Function Among Young Adults With Early Life Adve · NA · recruiting
- NCT07152912 — Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy · NA · recruiting
- NCT07369232 — Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT) · NA · recruiting
Other Universidade Federal de Santa Maria trials
Trials by the same sponsor.
- NCT07584460 — Juçara (Euterpe Edulis Martius) Supplementation Effect in Muscle Protection, Performance and Soreness in Lower Limbs Aft · NA · completed
- NCT05948722 — Behavioral Intervention Program Based on Motivational Interview · NA · active not recruiting
- NCT06371287 — Effect of Musical Auditory Training on Subjects With Tinnitus Disorder · NA · recruiting
- NCT04418700 — Effects of the Breath Stacking Technique After Upper Abdominal Surgery · NA · completed
- NCT04262011 — Effect of Non-surgical Periodontal Treatment and C-reactive Protein Levels in Hemodialysis Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03820245 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal de Santa Maria
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03820245.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing